Comparative efficacy of oral drugs for chronic radiation proctitis - a systematic review.
Chronic radiation proctitis
Diarrhoea
Oral treatments
Radiation toxicity
Rectal bleeding
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
22 08 2023
22 08 2023
Historique:
received:
21
03
2022
accepted:
20
07
2023
medline:
24
8
2023
pubmed:
23
8
2023
entrez:
23
8
2023
Statut:
epublish
Résumé
Chronic radiation proctitis (CRP) is a long-term complication of pelvic radiotherapy that manifests as rectal bleeding, diarrhoea, fistula formation and obstruction. Treatments such as endoscopic argon plasma coagulation, hyperbaric oxygen therapy and rectal topical formalin have imposed a significant medical burden on CRP patients. In contrast, oral therapies offer a more accessible and acceptable option for managing CRP. Here, we conducted a systematic review of the efficacy of oral treatments for CRP to assess their potential as an effective and convenient treatment option for this condition. We searched the Cochrane Central Register of Controlled Trials, PubMed, Web of Science, China National Knowledge Infrastructure and Chinese VIP in February 2021. We included post-radiotherapy participants with CRP that compared oral medicine alone or in combination with other treatments versus control treatments. The primary outcomes were bleeding, diarrhoea and symptom score. Heterogeneity between studies was checked using Cochrane Q test statistics and I We included 10 randomised controlled trials (RCTs) and 1 retrospective study with 898 participants. Three placebo-controlled trials evaluated the effects of oral sucralfate on CRP, with meta-analysis showing no significant different with placebo arm. Four trials on TCM demonstrated significant improvement of symptoms, especially for the 3 trials on oral TCM drinks. Retinyl palmitate and high-fibre diet were found to reduce rectal bleeding. The combination of oral pentoxifylline and tocopherol did not significantly change the process of CRP. Our study implies that oral TCM drinks, retinyl palmitate and a high-fiber diet showed significant improvement in CRP symptoms, but not with the combination of oral pentoxifylline and tocopherol. Further multicentre, larger-scale RCTs are needed to confirm the efficacy and safety of these treatments and optimize treatment strategies, ultimately improving the quality of life for patients with CRP.
Sections du résumé
BACKGROUND
Chronic radiation proctitis (CRP) is a long-term complication of pelvic radiotherapy that manifests as rectal bleeding, diarrhoea, fistula formation and obstruction. Treatments such as endoscopic argon plasma coagulation, hyperbaric oxygen therapy and rectal topical formalin have imposed a significant medical burden on CRP patients. In contrast, oral therapies offer a more accessible and acceptable option for managing CRP. Here, we conducted a systematic review of the efficacy of oral treatments for CRP to assess their potential as an effective and convenient treatment option for this condition.
METHODS
We searched the Cochrane Central Register of Controlled Trials, PubMed, Web of Science, China National Knowledge Infrastructure and Chinese VIP in February 2021. We included post-radiotherapy participants with CRP that compared oral medicine alone or in combination with other treatments versus control treatments. The primary outcomes were bleeding, diarrhoea and symptom score. Heterogeneity between studies was checked using Cochrane Q test statistics and I
RESULTS
We included 10 randomised controlled trials (RCTs) and 1 retrospective study with 898 participants. Three placebo-controlled trials evaluated the effects of oral sucralfate on CRP, with meta-analysis showing no significant different with placebo arm. Four trials on TCM demonstrated significant improvement of symptoms, especially for the 3 trials on oral TCM drinks. Retinyl palmitate and high-fibre diet were found to reduce rectal bleeding. The combination of oral pentoxifylline and tocopherol did not significantly change the process of CRP.
CONCLUSIONS
Our study implies that oral TCM drinks, retinyl palmitate and a high-fiber diet showed significant improvement in CRP symptoms, but not with the combination of oral pentoxifylline and tocopherol. Further multicentre, larger-scale RCTs are needed to confirm the efficacy and safety of these treatments and optimize treatment strategies, ultimately improving the quality of life for patients with CRP.
Identifiants
pubmed: 37608385
doi: 10.1186/s13643-023-02294-2
pii: 10.1186/s13643-023-02294-2
pmc: PMC10464232
doi:
Substances chimiques
retinol palmitate
1D1K0N0VVC
Pentoxifylline
SD6QCT3TSU
Tocopherols
R0ZB2556P8
Types de publication
Systematic Review
Meta-Analysis
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
146Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Grodsky MB, Sidani SM. Radiation proctopathy. Clin Colon Rectal Surg. 2015;28(2):103–11 . [cited 2021 Feb 4].
doi: 10.1055/s-0035-1547337
pubmed: 26034407
pmcid: 4442718
Babb RR. Radiation proctitis: a review. Am J Gastroenterol. 1996;91(7):1309–11.
pubmed: 8677984
Rustagi T, Mashimo H. Endoscopic management of chronic radiation proctitis. World J Gastroenterol. 2011;17:4554–62.
doi: 10.3748/wjg.v17.i41.4554
pubmed: 22147960
pmcid: 3225092
Ashcraft KA, Miles D, Sunday ME, Choudhury KR, Young KH, Palmer GM, et al. Development and preliminary evaluation of a murine model of chronic radiation-induced proctitis. Int J Radiat Oncol Biol Phys. 2018;101(5):1194–201. https://doi.org/10.1016/j.ijrobp.2018.04.061 .
doi: 10.1016/j.ijrobp.2018.04.061
pubmed: 30012529
Zinicola R, Rutter MD, Falasco G, Brooker JC, Cennamo V, Contini S, et al. Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy. Int J Colorectal Dis. 2003;18(5):439–44.
doi: 10.1007/s00384-003-0487-y
pubmed: 12677457
Gibson RJ, Keefe DMK, Lalla RV, Bateman E, Blijlevens N, Fijlstra M, et al. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer. 2013;21:313–26.
doi: 10.1007/s00520-012-1644-z
pubmed: 23142924
van de Wetering FT, Verleye L, Andreyev HJN, Maher J, Vlayen J, Pieters BR, et al. Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2016;2016
Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V. Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol. 2010;5(1):31. https://doi.org/10.1186/1748-717X-5-31 .
doi: 10.1186/1748-717X-5-31
pubmed: 20444243
pmcid: 2874795
Jiang W, Wu N, Wang X, Chi Y, Zhang Y, Qiu X, et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep. 2015;5:8096.
doi: 10.1038/srep08096
pubmed: 25644696
pmcid: 4314632
Yang JH, Yoo JM, Cho WK, Ma JY. Anti-inflammatory effects of Sanguisorbae Radix water extract on the suppression of mast cell degranulation and STAT-1/Jak-2 activation in BMMCs and HaCaT keratinocytes. BMC Complement Altern Med. 2016;16(1):347.
doi: 10.1186/s12906-016-1317-4
pubmed: 27599590
pmcid: 5011966
Zhang X, Tian R, Zhao C, Birch S, Lee JA, Alraek T, et al. The use of pattern differentiation in WHO-registered traditional Chinese medicine trials – a systematic review. Eur J Integr Med. 2019;1(30): 100945.
doi: 10.1016/j.eujim.2019.100945
Chen B, Liang J. Clinical study on treatment of radiation proctitis with Bupi-Qingchang recipe combined with Chinese herbal enema. Int J Tradit Chinese Med. 2019;41(6):580–4.
Delia P, Sansotta G, Donato V, Messina G, Frosina P, Pergolizzi S, et al. Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol. 2002;97(8):2150–2.
doi: 10.1111/j.1572-0241.2002.05946.x
pubmed: 12190202
Ciorba MA, Riehl TE, Rao MS, Moon C, Ee X, Nava GM, et al. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut. 2012;61(6):829–38.
doi: 10.1136/gutjnl-2011-300367
pubmed: 22027478
Liu W, Zhang J, Wu C, Cai S, Huang W, Chen J, et al. Unique features of ethnic Mongolian gut microbiome revealed by metagenomic analysis. Sci Rep. 2016;6:6.
Hibberd AA, Lyra A, Ouwehand AC, Rolny P, Lindegren H, Cedgård L, et al. Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. BMJ Open Gastroenterol. 2017;4(1):e000145.
doi: 10.1136/bmjgast-2017-000145
pubmed: 28944067
pmcid: 5609083
Ehrenpreis ED, Jani A, Levitsky J, Ahn J, Hong J. A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy. Dis Colon Rectum. 2005;48(1):1–8.
doi: 10.1007/s10350-004-0821-7
pubmed: 15690650
Krichevsky AM, Kosik KS, Aakalu G, Smith WB, Nguyen N, Jiang C, et al. Neuronal RNA granules: a link between RNA localization and stimulation-dependent translation. Neuron. 2001;32(4):683–96.
doi: 10.1016/S0896-6273(01)00508-6
pubmed: 11719208
Mete LS, Assisi D, Casale V. Efficacy of butyrate on rectal toxicity of radiotherapy in prostate cancer patients. Dig Liver Dis Suppl. 2007;1:23–6.
Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
doi: 10.1371/journal.pmed.1000097
pubmed: 19621072
pmcid: 2707599
Sterne JAC, Higgins JPT RB on B of the DG for A-N, Sterne J, Higgins J, Reeves B, on behalf of the development group for ACROBAT-NRSI. A Cochrane risk of bias assessment tool: for non-randomized studies of interventions (ACROBAT-NRSI). Version 100. 2014;
The Cochrane Collaboration. GRADEpro GDT. Cochrane Community. 2017.
Chruscielewska-Kiliszek MR, Regula J, Polkowski M, Rupinski M, Kraszewska E, Pachlewski J, et al. Sucralfate or placebo following argon plasma coagulation for chronic radiation proctitis: a randomized double blind trial. Color Dis. 2013;15(1):e48–55.
doi: 10.1111/codi.12035
Henriksson R, Franzén L, Littbrand B. Prevention and therapy of radiation-induced bowel discomfort. Scand J Gastroenterol Suppl. 1992;191:7–11.
doi: 10.3109/00365529209093223
pubmed: 1411296
Kneebone A, Mameghan H, Bolin T, Berry M, Turner S, Kearsley J, et al. Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: a double-blind, randomized trial. Int J Radiat Oncol Biol Phys. 2004;60(4):1088–97.
doi: 10.1016/j.ijrobp.2004.04.033
pubmed: 15519779
Jiang W, Lu J, Xin L, Wang J, Shen Z. Clinical study on the treatment of radiation enteritis by Hongyu decoction. SHAANXI J Tradit CHINESE Med. 2018;39(08):1008–10.
Xiao C. The evaluation of the moxibustion reduce the chronic radiation proctitis in the radiotherapy of cervical carcinoma. 2019.
Wang Z, Wang Q, Wang X, Zhu L, Chen J, Zhang B, et al. Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy. J Cell Mol Med. 2019;23(5):3747–56.
doi: 10.1111/jcmm.14289
pubmed: 30908851
pmcid: 6484301
Hille A, Christiansen H, Pradier O, Hermann RM, Siekmeyer B, Weiss E, et al. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol. 2005;181(9):606–14.
doi: 10.1007/s00066-005-1390-y
pubmed: 16170489
Wang Y. Effect of dietary fiber on nutritional status and immune function in patients with pelvic radiotherapy. 2019.
Yuan J. Clinical observation of Fuzheng Qingchang decoction combined with probiotics in the treatment of chronic radiotherapy proctitis after radiotherapy for cervical cancer (Rehan cuoza zheng). 2019.
Zhou Y. Meta-analysis of the efficacy of integrated traditional Chinese and Wetern medicine in the treatment of radiation proctitis. 2019.
Tan YQ, Chen HW, Li J, Wu QJ. Efficacy, chemical constituents, and pharmacological actions of Radix Paeoniae Rubra and Radix Paeoniae Alba. Front Pharmacol. Frontiers Media S.A.; 2020;11.
Pareek P, Samdariya S, Sharma A, Gupta N, Shekhar S, Kirubakaran R. Pentoxifylline and vitamin E alone or in combination for preventing and treating side effects of radiation therapy and concomitant chemoradiotherapy. Cochrane Database of Systematic Reviews. 2016;2016(3):CD012117.
pmcid: 6457585
Venkitaraman R, Coffey J, Norman AR, James FV, Huddart RA, Horwich A, et al. Pentoxifylline to treat radiation proctitis: a small and inconclusive randomised trial. Clin Oncol. 2008;20(4):288–92.
doi: 10.1016/j.clon.2008.01.012
EUCTR2012-004211-31-GB. PPALM - palm oil and pentoxifylline against late morbidity. 2014.
Lund JÅ, Kaasa S, Wibe A, Widmark A, Fransson P. Late radiation effects to the rectum and anus after treatment for prostate cancer; validity of the LENT/SOMA score. Acta Oncol. 2013;52(4):727–35.
doi: 10.3109/0284186X.2013.747695
pubmed: 23398595
Syndikus I, Morgan RC, Sydes MR, Graham JD, Dearnaley DP. Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397). Int J Radiat Oncol Biol Phys. 2010;77(3 CC-Gut CC-Urology):773–83.
doi: 10.1016/j.ijrobp.2009.05.052
pubmed: 19836155
pmcid: 2937212
Esco R, Valencia J, Coronel P, Carceller JA, Gimeno M, Bascón N. Efficacy of orgotein in prevention of late side effects of pelvic irradiation: a randomized study. Int J Radiat Oncol Biol Phys. 2004;60(4 CC-Colorectal CC-Pain, Palliative and Supportive Care CC-Gynaecological, Neuro-oncology and Orphan Cancer):1211‐1219.
Sidik S, Hardjodisastro D, Setiabudy R, Gondowiardjo S. Does hyperbaric oxygen administration decrease side effect and improve quality of life after pelvic radiation? Acta Med Indones. 2007;39(4 CC-Complementary Medicine CC-Gynaecological, Neuro-oncology and Orphan Cancer CC-Gut):169‐173.
EUCTR2007-002082-13-DE. Randomised, double-blind, placebo-controlled, multicentre, comparative phase II pilot study on the efficacy and tolerability of an 8-week rectal treatment with 2 mg budesonide or placebo for the prevention of acute radiation proctitis - budesonide foam ve. 2009.
Altomare R, Damiano G, Abruzzo A, Palumbo VD, Tomasello G, Buscemi S, et al. Enteral nutrition support to treat malnutrition in inflammatory bowel disease. Nutrients. MDPI AG; 2015;7:2125–33. Available from: /pmc/articles/PMC4425135/
Virizuela JA, Camblor-Álvarez M, Luengo-Pérez LM, Grande E, Álvarez-Hernández J, Sendrós-Madroño MJ, et al. Nutritional support and parenteral nutrition in cancer patients: an expert consensus report. Clin Transl Oncol. 2018;20(5):619–29.
doi: 10.1007/s12094-017-1757-4
pubmed: 29043569
Lu W, Xie Y, Huang B, Ma T, Wang H, Deng B, et al. Platelet-derived growth factor C signaling is a potential therapeutic target for radiation proctopathy. Sci Transl Med. 2021;13(582):eabc2344.
doi: 10.1126/scitranslmed.abc2344
pubmed: 33627485